Peptide Therapy Marketing · Thymosin Alpha-1

Thymosin Alpha-1 Patient Lead Generation for Peptide Clinics

Written byTamerlan Musayev·Founder of PeptideLeads

Thymosin Alpha-1 is a quieter category than BPC-157 or Semaglutide, but the patients who search for it tend to be the most committed. They are often immunocompromised, recovering from long COVID, dealing with chronic infections, or actively working on immune optimization for longevity reasons. These patients know exactly what they want and they are rarely price-sensitive. PeptideLeads delivers them to your clinic for $50 per qualified lead. No retainer, we cover all ad spend, and founder Tamerlan Musayev built this specifically because clinics with Thymosin Alpha-1 programs are often invisible to the patients who need them.

The Market Context

Thymosin Alpha-1 search volume is lower than the headline peptides but the intent behind each search is extremely high. Monthly branded searches in the United States run between 20,000 and 40,000, with notable spikes after any mainstream immune or longevity podcast mentions it. The patient demographic skews slightly older, 40 to 65, and includes a meaningful portion of patients with autoimmune or chronic illness histories. Another segment is high-performers focused on longevity who have read about Thymosin Alpha-1 in the context of cellular immunity and aging. Both segments convert well because neither is shopping on price.

Why This Works

Because Thymosin Alpha-1 patients are often dealing with significant health issues, their urgency to start treatment is higher than the average peptide patient. That translates into fast close rates once the lead reaches an informed intake team. First-year revenue per patient typically lands between $3,000 and $6,500 depending on protocol length. At $50 per lead with typical close rates of 30 to 40 percent, the economics are extremely favorable. This is one of the categories where even a small volume of leads produces meaningful clinic revenue.

How Our Process Works

We run paid campaigns on Meta and Google, plus targeted placements in health and longevity contexts. Ad creative speaks to immune function, recovery, and chronic illness scenarios without making claims that trigger ad platform reviews. Qualification questions capture state, primary health concern, prior treatment history, and start timeline. We verify phone numbers before delivery. You receive a complete lead profile. We cover the ad spend. You pay $50 per qualified lead.

What Makes Us Different

Running Thymosin Alpha-1 campaigns requires careful language because of the sensitive health context involved. Most agencies either get too aggressive with claims and get their accounts flagged, or get too cautious and stop reaching the patients who need the treatment. We know where the line is because we run these campaigns constantly. That operational knowledge is the difference between a campaign that produces patients and a campaign that burns through ad spend with nothing to show for it.

$50 Per Lead. No Retainer. We Cover All Ad Spend.

If your clinic offers Thymosin Alpha-1 and you want to reach the patients who need it, let's talk. $50 per lead, no retainer, full ad spend coverage.

Book a 30-Minute Call Get Matched

Frequently Asked Questions

What kind of patients search for Thymosin Alpha-1?

Long COVID patients, autoimmune patients, chronic infection patients, and longevity-focused optimizers. Most are highly educated about their condition and ready to start treatment.

What comes with each lead?

Full name, phone, email, state, primary health concern, treatment history, and start timeline. Phone is verified before delivery.

How many Thymosin Alpha-1 leads can I expect per month?

Volume is lower than BPC-157 or Semaglutide but intent is higher. Most clinics see 10 to 30 leads per month depending on service area.

Do you cover ad spend for these campaigns?

Yes. We cover all ad spend. Your only cost is $50 per qualified lead.

Is there a contract?

No. No retainer, no contract, no minimum. You can stop any time.